Procaps Group S.A. (PROC)

2.7499 -0.2101 (-7.10%) At close: 04:00PM EDT

Procaps Group S.A.

9 Rue de Bitbourg
Luxembourg City 1273
Luxembourg
356 7995 6138
https://www.procapsgroup.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 5,500

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ruben Minski	Founder & Executive Chairman	N/A	N/A	1953
Mr. Jose Antonio Toledo Vieira	Chief Executive Officer	N/A	N/A	1966
Mr. Patricio Vargas Munoz	Global Chief Financial Officer	N/A	N/A	1973
Dr. Camilo Camacho	Chief Operations Officer	N/A	N/A	1974
Ms. Melissa Angelini	Investor Relations Director	N/A	N/A	N/A
Ms. Marcela Carvajalino Pagano	Vice-President of Corporate & Legal Affairs	N/A	N/A	1967
Mr. Luis Alberto Palacios Aragon	Vice-President of International Marketing and R&D	N/A	N/A	1964
Mr. Mauricio Castaneda Caballero	Vice-President of Human Resources	N/A	N/A	1977
Mr. Carlos Piocuda Russo	Head of Optimization of Corporate Value & Corporate VP of Finance	N/A	N/A	1985

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.

Corporate governance

Procaps Group S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.